Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis

By News Health
8 hours Ago

(MedPage Today) — The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retrospective cohort study.
Among over 19,000 matched…

Source link : https://www.medpagetoday.com/dermatology/psoriasis/116153

Author :

Publish date : 2025-06-18 20:22:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Dupilumab Linked to Higher Psoriasis Risk in AD

Rapamycin seems to boost longevity as effectively as eating less

Is One Fasting Method Better Than Another?

28 Years Later review: Danny Boyle's long-awaited zombie sequel is a triumph

Study Sheds Light on Links Between Sweetened Drinks and Dementia

Doc's Hidden Camera; Husel's Defamation Suit Tossed; Fugitive Doctor Sentenced